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I SHOULD first wish to pay tribute to, and honour the memory of, a distinguished
surgeon - a man of broad interests, a dogmatic teacher of no mean ability, an
administrator with a social conscience. In this spirit, and conscious of the privilege
that is mine of being invited to follow in this Lectureship some very eminent
medical men, I make bold to suggest for consideration a topic that would have
fascinated and intrigued its founder, A. B. Mitchell. From what I can gather, he
enjoyed getting his teeth into problems that seemed at first sight too big for him.
The topic before us is: "Leprosy - a clinical and pathological challenge". Before
we consider what leprosy is, we should say what it is not, thereby removing some
misconceptions and misunderstandings, and demolishing some cherished idols and
pseudo-scientific folklore enshrined in medical text books and Bible diction-aries.
Leprosy is not a highly contagious infection. It is not an invariably progressive
disease, leading inevitably to mutilation and deformity. It is not a disease that is
virtually incurable, one in which the fingers and toes drop off. It is not a mysterious
condition somehow associated with Divine punishment for wrongdoing or cere-
monial uncleanness, or with ritual defilement. It is not a condition invariably
associated with poverty or beggary, or with dirt and squalor. It is not a fearful
combination of the supposed incurability of cancer, the contagiousness of tuber-
culosis and the shame of venereal disease.
If leprosy is none of these things, what is it? It is a slightly contagious disease,
caused almost certainly by a mycobacterium of low pathogenicity that has weak
powers of invasion. It is usually self-limiting and self-healing. It is endemic in cold
as well as in hot countries. It is characterized not only by disfiguring hypopigmented
skin patches and nodules and by invasion of the mucosa of the upper respiratory
tract, but also pre-eminently and most importantly by damage to the peripheral
nerves. It is not necessarily associated with dirt, poverty, overcrowding or poor
hygiene, although each of these factors may have something to do with its spread,
or with its persistence in any one focus. It is, of course, unassociated with venereal
transmission, and should bear no connotation of shame.
Clinically and pathologically, leprosy is several conditions, and as such it
presents a continuing challenge to those interested in disease and sequelae of
disease, in human suffering and in economic loss. It is, firstly, an infection by
Mycobacterium leprae of the dermis, the mucosa of the upper respiratory tract and
the peripheral nerves. It is of insidious onset, and the source of infection is often
unknown. The disease itself is characterized by extremely slow progress. Leprosy is
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in sudden epidemics, and it carries no high mortality.
Leprosy, however, is not only a mycobacterial infection: it represents, secondly,
the summation of a variable cellular response to infection. On the one hand, bacilli
may be very scanty, multiplying apparently with great difficulty; the presence of
rare bacilli is accompanied by a vigorous cellular reaction. On the other hand, there
may be an enormous parasitization of the reticulo-endothelial cells of the dermis,
and a bacillary invasion of all the peripheral nerves. It is the host-response to the
infection that determines the nature of the clinical disease.
In the third place, leprosy represents the mechanical - rather than the toxic -
effects of this response. Tuberculoid leprosy is characterized histopathologically and
clinically by a progressive destruction by fibrosis of sweat glands, pigment-forming
cells of the basal layer of the epidermis, hair follicles, nerve endings and nerve
fibres; at length, when the granuloma involves the reticular layer, the fibrotic
constriction of important structures leads to functional ablation. This latter type
of destruction occurs, for example, in a superficial nerve immediately subjacent
to a minor tuberculoid lesion, and necessarily partakes in the localized fibrosis
following a vigorous cellular response to paucibacillary infection; or in the nasal
duct involved in a progressive fibrotic process with consequential epiphora and
ulceration of the facial skin. Extremely numerous bacilli may be aggregated
together in masses of Virchow, lepra or foamy cells, the whole protruding as a
lepromatous nodule. Such masses of highly bacilliferous granulomata may be
present diffusely in the dermis or in the mucosa of the upper respiratory tract.
There are smaller and clinically less important aggregations in the liver, the bone
marrow and the spleen.
It is in the peripheral nerves that the fibrosis following degeneration of myco-
bacteria has its most serious and far-reaching consequences. Enormous numbers of
viable and morphologically normal mycobacteria may exist and multiply between
the fibres of the peripheral nerves without provoking an inflammatory response,
but when these bacilli degenerate and attract an outpouring of lymphocytes with
an accompanying oedema, nerve pathways may be temporarily interrupted or
permanently destroyed.
In the fourth place, leprosy may be regarded as the peripherally distant results
of this temporary or irreversible damage to nerve fibres; these results primarily
interest the surgeon - the plastic and orthopaedic surgeon, and the ophthalmic
surgeon. Partial pareses and complete paralyses develop in the intrinsic muscles of
the hands and feet, and in the facial muscles. Paraesthesiae and areas of numbness
that are persistent or localized or recurrent, may precede total sensory anaesthesia.
The first modality to be lost is usually that of light touch. Heat and cold soon
follow, and then pain. The deep reflexes are usually retained, as are muscle and
joint sense and vibration sense in bone. Notwithstanding the very extensive and
severe sensory loss, stereognosis is often retained to a surprising degree. Changes
may occur in the calibre of blood vessels, in local reflexes on stimuli, in pigment
formation and in sweating in the direction of hypo- or hyper-idrosis.
In the fifth place, leprosy may be regarded as demonstrating the phenomena of
tissue sensitization, or as the manifestations of an antigen-antibody reaction. In
this respect leprosy has many features suggestive of auto-immune disease, and its
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examples of hypersensitive phenomena are to be seen pre-eminently in the iris and
ciliary body, and in the subcutaneous tissues; in the latter the manifestations may
be classed as those of erythema nodosum leprosum, the lesions of which may be
discrete and acuminate, or a more diffuse, generalized and coalescent panniculitis.
This is accompanied in severe cases by inflammation of the lymph nodes, by
polyarthritis going on to effusion into the medium-sized joints, by acute anaemia
and gynaecomastia, sometimes associated with orchitis and testicular atrophy. Such
systemic symptoms as pyrexia, severe malaise, and pain in nerves, muscle masses
and joints, coupled with the presence of C-reactive protein in the serum, cryo-
proteins, increased gamma-globulin, and (occasionally) LE cells - all suggest some
complex disturbance of the body response-system.
Lastly, leprosy may be regarded not only as any or all of the above manifesta-
tions of a disease process, but also as an attitude of mind - in the patient and his
entourage, in society, in governments and legislative bodies. There are countries
where this aspect of leprosy is its most important feature, outweighing in seriousness
the controllable contagion caused by Myco. leprae. Attitudes, misconceptions and
prejudices are often more difficult to change and eradicate than physical entities.
Wherein lies the clinical challenge of leprosy?
Leprosy is overlooked or wrongly diagnosed, with great frequency. The time-lag
between the first sign and correct diagnosis is often several years. Since all patients
at present under treatment in Great Britain have contracted the disease abroad,
leprosy should be considered in the differential diagnosis of any dermatosis or
neuropathy in anybody who has travelled out of the country, and especially in
contacts of known cases. We should think of leprosy when faced with any obscure
dermatosis - or any chronic non-irritating skin condition that either does not
resemble one of the commoner categorized dermatoses or fails to respond to usually
effective treatment. A peripheral neuritis whose aetiology is not apparent, and
especially if accompanied by some kind of skin rash, may be due to leprosy.
The positive signs of diagnosis of leprosy may be summarized as follows:
a localized area of skin showing altered pigmentation, impaired tactile sensibility,
loss of sweating, disturbance of hair growth, and, of course, the presence of Myco.
leprae. If the practitioner awaits all these conditions - or the majority - he will fail
to diagnose early leprosy and even the advanced disease. The earliest stages may
be represented by vague prodromal symptoms of paraesthesiae, evanescent lesions
and, very importantly, self-healing lesions.
The second aspect of the clinical challenge of leprosy concerns the differential
diagnosis of the disease. This is too vast a subject to discuss fully. Leprosy may
be - and very often is - confused with almost any dermatosis, with congenital
conditions, with skin infections and neoplasms. One very common neurological sign
in leprosy, almost pathognomonic, is frequently overlooked. The peripheral nerve
trunks, especially at sites of predilection, where they course superficially or near
joints, are enlarged and hard and tender. This sign, confined to one nerve or present
in all the main peripheral nerve trunks, is encountered very infrequently in such
rarities as: generalized amyloidosis of nerves, and Dejerine Sotta's disease
(Thevenard's syndrome, or congenital hypertrophic familial polyneuritis). In cases
of congenital indifference to pain, the nerve trunks are clinically normal.
125The third aspect of this challenge concerns the acute exacerbation of lepromatous
leprosy, characterized by a more or less sudden appearance, and a more or less
prolonged persistence, of features of the hypersensitive state. Many fundamnental
questions concerning pathogenesis and treatment remain unanswered. In the case
of acute irido-cyclitis, or sudden widespread and severe polyneuritis, the clinical
results are serious and may be permanent.
The fourth aspect of this challenge concerns the nerve damage in leprosy. Why
the predilection for peripheral nerves, and the sparing of the central nervous
system? Why the damage to certain modalities, or to certain levels of the nerve?
The clinical impairment may be mainly motor or mainly sensory, or any combina-
tion of the two and to any degree. The affection may be transient or permanent.
The auto-sensitization of nerve tissue by products of nerve damage, and the
enhancement of a non-specific effect by extracts obtained from other mycobacteria,
are two aspects of this problem that may have important bearings on the patho-
genesis of auto-immune disease in general.
These considerations have a bearing on the practical problems confronting the
surgeon, problems such as acute foot-drop, sudden orbicularis paralysis, other
paralyses, deformities, contractures, ulceration of anaesthetic extremities, etc. All
these conditions would be preventible if only leprosy were diagnosed early and
treated properly. Moreover, at whatever stage active leprosy is encountered in the
individual patient, further damage to nerves and the consequences of such damage
may be corrected by judicious application of known surgical principles.
An indispensable adjunct to surgery is physiotherapy; in point of fact, the actual
surgical intervention may be regarded as an interlude in the prolonged and exacting
task of the physiotherapist who not only aims at restoring paresed muscles to
useful function and re-educating the patient, e.g., after tendon-transfer operations,
but who plays an important role in counselling the patient to care for his anaesthetic
extremities.
Another valuable member of the team is the shoemaker, who utilizes locally
available materials and locally available skills to produce cheap and durable and
acceptable protective footwear. The splint and brace-maker and the prosthetist
complete the team as far as physical restoration and rehabilitation are concerned.
The damage done by leprosy, however, must be considered also in relation to its
mental, social and even its spiritual aspects. These together constitute a tremendous
challenge to those whose objective is the restoration of the individual sufferer to
integrity and usefulness as a person in his community.
THE PATHOLOGICAL CHALLENGE
The problems in leprosy awaiting solution are of importance not only to the
study of leprosy itself and to related mycobacterial infections, but also to general
medicine and surgery, to epidemiology, immunology and bacteriology. Their
solution depends in turn upon advances in related branches and upon the utilization
of modern investigative aids and tools. The cross-fertilization of ideas that produces
results could come from research workers now tackling problems in related
disciplines (such as tuberculosis or auto-immune disease). In the past, leprologists
have unfortunately been isolated and segregated from their fellows. Let us glance
briefly at some of these pathological challenges.
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cited as the cause of human disease, it has not yet been cultured in vitro.
Secondly, until recently it has been impossible to reproduce in the experimental
animal a generalized progressive granulomatous disease.
Thirdly, the fundamental questions of resistance and susceptibility await solu-
tion: the exact significance of the Mitsuda test in this connection is still obscure,
and potential response to mycobacterial antigen injected intradermally may not
also indicate potential resistance if the subject should be challenged by leprosy
infection.
In the fourth place, the transmission of leprosy provides another series of patho-
logical problems still unsolved. The sole orthodox nidus of Myco. leprae is human
tissue, but its existence in fomites or its persistence after being shed outside the
human body has not been demonstrated. Viral forms or L-forms may indeed exist,
whose importance in the transmission of leprosy is quite unsuspected. The actual
inoculation and implantation of the bacillus also provides many unanswered
questions. The long silent, or latent, or incubation period of several years awaits
elucidation. (A partial explanation, of course, resides in the prolonged geneiation
time of this bacillus, probably a matter of two or three weeks). Why does the leprosy
bacillus invade the tissues apparently with ease in some patients and fail to
establish itself in others? Is susceptibility genetically determined? Does it depend
upon an initial unnoticed inoculation, which results in a tissue hypersensitivity?
Is a positive lepromin test associated with infection by related mycobacteria, named
or anonymous?
In the fifth place, skin hypersensitivity in leprosy has intriguing parallels with
granulomata produced by beryllium, zirconium and silicon, and with antigenic
extracts of liver, skin, etc.
Then there is the range of sarcoid phenomena in lymph nodes, skin, eye, bone,
etc. Other mycobacterial infections show some resemblances to the chronic granulo-
mata caused by or associated with Myco. leprae: tuberculosis, swimming-bath
granuloma, Buruli ulcer (Myco. ulcerans sp.), Stefansky's infection in rodents, and
infection by related mycobacteria in water buffalo, wood-pigeons, salmon, frogs,
snakes, etc.
I may now refer to recent experimental work that is furnishing some long-awaited
answers to these and other questions. The inoculation of leprosy bacilli into the
footpad of the mouse will result in mathematically demonstrable multiplication of
the bacilli after a prolonged period (to be correlated with the prolonged generation
time of the bacillus). This elegant demonstration of a localized bacillary multiplica-
tion is not to be confused with generalized mycobacterial granulomatous disease,
but it does provide definite evidence that Myco. leprae is viable and can multiply
within the special conditions of the biological experiment.
This technique is now being used as a screening procedure, to demonstrate the
activity of drugs, drug-resistance, and the enhancement of resistance to leprosy by
B.C.G. inoculation. The minimal inhibitory doses of standard drugs employed in
leprosy can be determined, and, in fact, the method has shown that such drugs as
dapsone and B 663 (Geigy), a phenazine derivative, are potent in extremely low
concentrations.
It has recently been demonstrated that thymectomized mice who have been
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granulomatous disease after inoculation with Myco. leprae. The granulomatous
masses contain morphologically normal Myco. Ieprae surrounded by a cellular
exudate and infiltration that is comparable with that seen in the human subject
with lepromatous disease.
Much work is also proceeding on the changes in the serum consequent upon
leprosy infection. The gamma-globulins are increased, and cryoproteins have been
recently demonstrated. This subject presents a considerable challenge to the bio-
chemist and the immunologist. The common antigenic pattern of several related
mycobacteria has been demonstrated by biochemical and immunological methods.
CONCLUSION AND SUMMARY
Such is leprosy, one of the earliest human infections to be associated with a
specific micro-organism - and one of the latest to yield its secrets to research.
Surrounded by more superstitution and prejudice than any other condition known
to medical science, leprosy still constitutes a tremendous challenge, clinically and
pathologically, scientifically and socially. It is the world's greatest crippler, yet it
has received but scant notice on this count. It is the last of the great infectious
endemics to reveal its mode of transmission and many of its epidemiological secrets.
Although five millions have been cured of leprosy within the last twenty years,
there are fifteen millions who suffer today, and within the next five years another
million will probably develop leprosy and another quarter of a million will become
crippled because of leprosy. This constitutes a clinical and pathological challenge
that would have stirred the scientific and humanitarian heart of A. B. Mitchell.
N.B. Rather than overload the lecture with numerous references to the literature, I would
direct attention to recent issues of The International Journal of Leprosy and other Myco-
bacterial Diseases, Leprosy Review, and the monthly abstracts and annual reviews appearing in
Tropical Diseases Bulletin. Nearly all significant research work in leprosy finds its way into
one or other of these publications.
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